Executive Management Team
Alice A. Jackson, R.N.
Chief Executive Officer
Co-Founder, Lifetree Clinical Research®
Ms. Jackson has been fully immersed in the pharmaceutical industry since 1989. Her experience encompasses every aspect of the clinical research process from protocol writing to project management and operational administration of multi-state research trials. To date, Ms. Jackson has actively executed and or managed over 500 Phase I-III research protocols.
Trained as an RN, Ms. Jackson worked in a medical setting for over 13 years. She has a comprehensive understanding of the science behind pharmaceutical formulations, as well as first-hand knowledge regarding the needs of medical providers and patients.
Ms. Jackson has combined her leadership and clinical talents to excel in the professional realm of clinical trial research focused primarily in analgesia. She advanced from Study Coordination and Project Management at a small site in Salt Lake City to become Senior Director of Clinical Site Operations for a large out-of state CRO. While Senior Director, Ms. Jackson contributed significantly to the developed of the acute post-operative bunionectomy model. Her contributions to the post-operative bunionectomy model are now recognized worldwide as the standard for acute pain drug development.
In 2003, Ms. Jackson joined forces with Lynn R. Webster, MD to found Lifetree Clinical Research®. As President and Chief Executive Officer, Ms. Jackson has led Lifetree to experience exponential growth. In 2006 alone, the company grew from 13 to 46 employees, and revenues increased 98 percent. Lifetree is currently the most highly-respected and fastest-growing clinical research organization in the Mountain West Region.
Ms Jackson was President of the Salt Lake City Chapter of ACRP in 2004. The chapter was in its infancy and she facilitated top regulatory and FDA speakers to educate other research professional within the community. Recently, Ms Jackson was asked to serve on the Utah Technology Council’s Life Science Advisory Council.
Ms. Jackson’s uncompromising drive for excellence and quality research will undoubtedly promise to build Lifetree’s propensity in forging new frontiers within the biopharmaceutical industry.
Lynn R. Webster, MD, FACPM, FASAM
Medical Director, Lifetree Clinical Research & Pain Clinic
President, Utah Academy of Pain Medicine
Chief of Anesthesiology, Health South Salt Lake Surgical Center
Dr. Webster earned his Doctorate of Medicine from the University of Nebraska Medical Center and completed his residency in the University of Utah Medical Center’s department of anesthesiology. He is board certified in pain medicine by the American Academy of Pain Medicine and has added qualifications in pain medicine from the American Society of Anesthesiologists. He is also certified in addiction medicine. He lectures extensively on the subject of preventing opioids abuse and criminal diversion in chronic pain patients, and he has authored over 100 scientific abstracts, journal articles. He recently published a book entitled Avoiding Opioid Abuse While Managing Pain: A Guide for Practitioners. This book was written for clinicians who prescribe opioids as a guide to sort out the clinical, regulatory, and ethical issues associated with the prescribing of opioids analgesics.
Dr. Webster is cofounder and medical director of Lifetree Clinical Research. His research interests are diverse. He has been keenly interested in working with industry to develop safer and more effective therapies for chronic pain and addiction. He has been a leading researcher exploring the relationship of medications and sleep, with particular interest in analgesic induced sleep disordered breathing.
Dr. Webster is currently on the board of directors for the American Academy of Pain Medicine and the National Pain Foundation. He was also instrumental in launching the Utah chapter of the American Academy of Pain Medicine. He is a co-editor of Pain Medicine’s section on Opioids, Substance Abuse and Addiction. He also is a reviewer for numerous peer reviewed journals. He was the Interventional Therapies section editor for Practical Pain Management for 2006 and 2007.
Dr. Webster is the co-founder of LifeSource, a non-profit foundation established in 2006 to educate physicians, patients and communities on health issues (with an emphasis on pain related, scientific and social issues), as well as fund and conduct research that will discover new solutions and hope for improved life. LifeSource’s first project is entitled “Zero Unintentional Deaths”, www.zerodeaths.org . The campaign was developed to educate physicians, chronic pain sufferers and all communities about the increasingly serious issue of unintentional overdose deaths relating to methadone and other prescription medications. It aims to eliminate unintentional overdoses from prescription medication.
Robert A. Medve, MD
Science and Regulatory Consultant
Dr. Medve earned his doctorate of medicine at Jefferson Medical College in Philadelphia, Pennsylvania, and he completed his residency in the anesthesia department at Thomas Jefferson University Hospital. Dr. Medve has also completed a pain management fellowship at Roswell Park Cancer Institute in Buffalo New York and served on the staff at the Children’s Hospital of Buffalo.
Dr. Medve has held senior positions at Metaphore Pharmaceuticals, Johnson & Johnson and Knoll Pharmaceutical Company. He has experience in the planning and implementation of pre-clinical and clinical development programs, directing formulation development process, and serving as FDA liaison; he has also developed and managed post-marketing programs, negotiated product labeling, and developed promotional materials.
Dr. Medve has significant experience with regulatory issues related to pharmaceutical development in the US and Europe. He has filed numerous INDs, SNDAs and NDAs for new molecules, line extensions, combination products, modified-release formulations, and additional indications. He has met with FDA advisory boards and has a long history of cooperative and collegial relationships with the FDA. He has frequently served as a primary spokesperson for sponsors at FDA meetings.
Dr. Medve is also a pioneer and recognized expert in pediatric drug development.
Dr. Medve will be responsible for consulting with Lifetree Clinical Research® biopharmaceutical partners as they begin to map out their drug development plans for new pain medications. His over ten years’ hands-on experience in the development of analgesic drugs, many of which are now on the market worldwide, will be an asset to Lifetree’s clients in all stages of development.
Morgan R. Brown, CPA, MBA
Chief Financial Officer and Senior Vice President
Lifetree Clinical Research welcomes Mr. Brown as its Chief Financial Officer and Senior Vice President. Mr. Brown graduated Suma Cum Laude from Utah State University with a BS in accounting and earned his MBA from the University of Utah.
Mr. Brown brings to Lifetree over 15 years of experience. As a senior manager for KPMG in Salt Lake City, Mr. Brown managed multiple audit engagements, servicing private and publicly owned clients focusing on the financial services line of business. Mr. Brown also performed extensive research of complex business, accounting, and finance issues.
Mr. Brown transitioned to the research industry with a move to NPS Pharmaceuticals. In his role as Vice President and Treasurer, he managed a large team, focusing on all aspects of accounting and finance. Mr. Brown participated in and was a critical member of the financing team for numerous financings including private and public equity offerings, convertible debt issuances, and secured financings, as well as a tender offer for the repurchase of outstanding convertible debt. In addition, Mr. Brown participated in NPS’ merger and acquisition activities. As a member of the Senior Management Team, Mr. Brown interacted with the outside Board of Directors, Audit Committee, and Compensation Committee. He also partnered with and provided day-to-day oversight of outside investment managers in the investment of approximately $300 million in cash and investment securities.
Mr. Brown is a results-driven Senior Finance Executive with extensive Leadership, Financing, and Operational experience who delivers a timely and accurate work product. Through his efforts he contributed significantly to strategic initiatives that lowered cash burn and increased performance for a Russell 200 public company. Additionally, a highly effective communicator, he is skilled in leading a large, multi-national finance and accounting team both internally and externally with the Wall Street investment community. A licensed Certified Public Accountant in Utah, Mr. Brown is Vice President of the Utah Chapter of the National Association of Stock Plan Professionals, a member of the American Institute of Certified Public Accountants, and a member of the Utah Association of Certified Public Accountants. With a proven track record managing all aspects of accounting and finance, Mr. Brown is a welcome asset to the Executive Management Team for Lifetree Clinical Research.
Greg Mann
Vice President
Business Development and Commercialization
Mr. Mann joined Lifetree Research in October 2007, as Vice President of Business Development and Commercialization. Mr. Mann has a B.S. degree from Brigham Young University where he graduated in Business Management and Marketing.
With over 23 years in the pharmaceutical, biopharmaceutical and research industries and having served in numerous, executive level leadership positions, in both Fortune 50 and small, biotechnology organizations, Mr. Mann brings a wealth of knowledge and experience to this position.
Mr. Mann began his career as a Medical Sales Representative but rapidly attained various promotions to numerous management roles. His work ethic, drive, integrity and motivation to be the best, at whatever position he holds, has led to significant leadership opportunities, including, Director of Sales Operations, Area Manager, National/Specialty Account Manager, and Vice President of Business Development, among others.
Throughout his career, Mr. Mann has maintained an exceptional record of demonstrated success, surpassing both profitability and productivity goal attainments, in each of his management positions, and has obtained extensive expertise in developing and leading cross functional, management teams. In addition, Mr. Mann has accumulated many national and regional sales and account management awards and has been recognized as ‘Rookie of the Year”, “Man of the Year”, “Regional Account Manager of the Year” and has obtained dozens of other sales and quality-oriented titles working with multinational pharmaceutical companies.
Kevin Jessing
Vice President, Bioanalytical Services
Mr. Jessing joined Lifetree Clinical Research® in April 2008 as Vice President of Bioanalytical Services. Mr. Jessing has Masters and Bachelors degrees in Biochemistry from The University of Texas at Austin.
Mr. Jessing has spent over 10 years in both contract and pharmaceutical research with an emphasis on pharmacokinetics, drug metabolism and mass spectrometry. He has established and overseen laboratory efforts within small pharmaceutical companies to address Absorption, Distribution, Metabolism and Excretion (ADME) properties of compounds in Discovery Phase as well as Good Laboratory Practice (GLP) compliant bioanalytical laboratories built to manage clinical and pre-clinical sample analysis. Having also spent a portion of his career in Applications and Sales, Mr. Jessing brings a deep understanding of the business process of serviced-based organizations within the biopharmaceutical industry.
In July 2007, Mr. Jessing founded Resonance Laboratories, LLC to provide a broad range of bioanalytical services to emerging pharmaceutical companies. In April 2008, Resonance Laboratories, LLC joined forces with Lifetree Clinical Research® to provide GLP and non-GLP Bioanalytical services to meet the needs of Lifetree’s expanding client base. Mr. Jessing’s background in both drug discovery and GLP bioanalysis positions him to anticipate potential bioanalytical difficulties in transitioning compounds into the clinical phase.
Tanji Goodfellow
Executive Director Quality Assurance
Tanji Goodfellow joined Lifetree Clinical Research® in June 2007. Goodfellow has over 23 years experience in the clinical research industry and has personally been involved with five new drug application approvals and numerous Food and Drug Administration (FDA) audits. Prior to joining the Lifetree Clinical Research® team, she was director of clinical operations at Cadence Pharmaceuticals in San Diego, Calif. where she was responsible for planning, execution and conduct of clinical research operations to ensure compliance with FDA regulations, established guidelines from the International Conference on Harmonization, and good clinical practice (GCP) guidelines. She has experience in the writing and development of clinical standard operating procedures, oversight of GCP training requirements for company staff and development, and execution of GCP audit plans for numerous clinical development programs.
Goodfellow has also worked for Biogen Idec Pharmaceuticals in San Diego, Calif., NovoNordisk Pharmaceuticals in Princeton, N.J., and for Anesta Corp, IOMED and Symbion in Salt Lake City, Utah.
Brad Bath, PhD, PMP
Executive Director Clinical Trials Management
Dr. Bath is the Executive Director of Clinical Trials Management at Lifetree Clinical Research®. He holds a Doctorate Degree in Analytical and Physical Chemistry as well as a Professional Certification in Project Management.
Dr. Bath has 12 years of experience in drug delivery/formulation and Phase 1-4 drug development with protein and peptide therapeutics as well as small molecule. He retains the distinction of first authorship of ten scientific articles published in professional journals as well as one book chapter, and continually focuses on innovative, efficient ways to develop drugs and optimize value to our clients.
Dr. Bath served as Lead Scientist in the development of three innovative drug delivery proj, ects. He has also developed Target Product Profiles and Minimally Acceptable Product Profiles ensuring development plans were synergistic with marketing strategies in Phase 1-4. The depth of Dr. Bath’s clinical knowledge, and his talent for applying this understanding to clinical research, allows Lifetree to efficiently plan and execute complex site and CRO projects. His proven expertise in building first-rate Project Management methodologies and managing high-performing global drug development teams is leveraged at Lifetree to deliver robustly-planned, quality-driven clinical projects to our clients.
Jack N. Bowe, SPHR
Director
Human Resources
Jack Bowe joined Lifetree Clinical Research® in July 2007. He is a certified senior professional in human resources and has over 20 years of experience in the field. Bowe comes to Lifetree Clinical Research® from SelectHealth, a division of Intermountain Healthcare, where he worked as a senior HR consultant. Previously he worked for PacifiCare, a Fortune 200 health services company based in Southern California, where he was a senior HR consultant managing six HR generalists and supporting over 2,000 employees in multiple locations. Bowe spent time volunteering with the Arizona Society for Human Resource Management State Council as legislative director where he had the opportunity to lobby legislators for changes to our current FMLA and FLSA laws. Bowe graduated from Brigham Young University with a master’s degree in counseling and a bachelor’s in chemistry.
